About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4942361
Allelic
Composition
Tg(Kit*D814V)2Roer/0
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Kit*D814V)2Roer mutation (0 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• diarrhea with bloody feces is seen in mice with intestinal inflammation
• in mice with intestinal inflammation
• numerous neutrophilic crypt abscesses are detected in several mice with intestinal inflammation
• inflammation results in extensive destruction of the mucosa with crypts separated from each other and from the lamina muscularis propria by the infiltrating cells
• outside of inflammatory lesions the colonic mucosa appears normal with the exception of an increase in mast cell numbers
• in mice with intestinal inflammation
• in all mice, regardless of pIpC treatment
• severity of inflammation varies and severe inflammation is more common in older mice
• inflammatory changes affect sharply demarcated patches of the mucosa and in most mice occur in long stretches of the mucosa
• most lesions are found in the cecum and ascending colon
• lesions are characterized by a massive infiltration of T cells, B cells, macrophages, and neutrophils with high numbers of mast cells found in the crypt epithelium surrounding the lesion
• the surface epithelium shows erosions in several mice
• in a few mice, regardless of pIpC treatment

hematopoietic system
• most of the mast cells in pIpC treated mice with mastocytosis are round with some degree of hypergranulation and only few spindle shaped cells are seen
• mice treated with 3 injections of pIpC every second day at 4 to 10 weeks of age develop diffuse mastocytosis by 13 - 38 weeks of age
• pIpC treated mice display a variable increase in cutaneous mast cell numbers
• in some pIpC treated mice accumulations of mast cells are seen in the lymph nodes, spleen, liver and/or stomach
• mice not treated with pIpC develop phenotypes similar to those in pIpC injected mice
• bone marrow cells are unable to engraft in nonirradiated recipient mice

neoplasm
• some pIpC treated mice develop large numbers of dermal mast cell tumors of variable size
• in a few mice these tumors are macroscopically visible
• mice not treated with pIpC develop phenotypes similar to those in pIpC injected mice

growth/size/body
• in mice with intestinal inflammation

integument
• some pIpC treated mice develop large numbers of dermal mast cell tumors of variable size
• in a few mice these tumors are macroscopically visible
• mice not treated with pIpC develop phenotypes similar to those in pIpC injected mice

immune system
• in all mice, regardless of pIpC treatment
• severity of inflammation varies and severe inflammation is more common in older mice
• inflammatory changes affect sharply demarcated patches of the mucosa and in most mice occur in long stretches of the mucosa
• most lesions are found in the cecum and ascending colon
• lesions are characterized by a massive infiltration of T cells, B cells, macrophages, and neutrophils with high numbers of mast cells found in the crypt epithelium surrounding the lesion
• the surface epithelium shows erosions in several mice
• in a few mice, regardless of pIpC treatment
• most of the mast cells in pIpC treated mice with mastocytosis are round with some degree of hypergranulation and only few spindle shaped cells are seen
• mice treated with 3 injections of pIpC every second day at 4 to 10 weeks of age develop diffuse mastocytosis by 13 - 38 weeks of age
• pIpC treated mice display a variable increase in cutaneous mast cell numbers
• in some pIpC treated mice accumulations of mast cells are seen in the lymph nodes, spleen, liver and/or stomach
• mice not treated with pIpC develop phenotypes similar to those in pIpC injected mice

endocrine/exocrine glands
• numerous neutrophilic crypt abscesses are detected in several mice with intestinal inflammation

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
mastocytosis DOID:350 OMIM:154800
J:169611


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory